Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy Ruchika Sharma14 April 2025 12:30 PM ISTBasel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...
Amgen colorectal cancer therapy gets USFDA nod Ruchika Sharma17 Jan 2025 12:29 PM ISTThe Food and Drug Administration has approved Amgen sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated...
USFDA nod to Pfizer Braftovi Combination Regimen for BRAF V600E-Mutant Metastatic Colorectal Cancer Ruchika Sharma21 Dec 2024 2:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) in combination with...
USFDA accepts application for Roche Columvi combination for relapsed or refractory diffuse large B cell lymphoma Ruchika Sharma5 Dec 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License...
Bristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal cancer Ruchika Sharma22 Jun 2024 11:11 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
USFDA approves Takeda Fruzaqla for previously treated Metastatic Colorectal Cancer Ruchika Sharma10 Nov 2023 1:51 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved FRUZAQLA (fruquintinib), an oral targeted therapy for...
Medical Bulletin 3/April/2023 Isra Zaman3 April 2023 3:45 PM ISTHere are the top medical news for the day:Risk of children developing lasting mental health problems increased by harsh disciplineIn a study of over...
Therapy that overcomes chemotherapy resistance in colon and rectal cancer validated in study Isra Zaman3 April 2023 9:15 AM ISTOxaliplatin along with other medications is often used to treat advanced colon or rectal cancer. A multidisciplinary team made up of doctors and...
Folfirinox prolongs survival in individuals with resected pancreatic ductal adenocarcinoma: Study Dr. Kamal Kant Kohli7 Sept 2022 6:15 AM ISTFRANCE: Patients with resected pancreatic ductal adenocarcinoma experience significantly longer survival with modified FOLFIRINOX compared with...
Combination chemotherapy improves survival in patients with pancreatic cancer Dr. Nandita Mohan16 July 2022 9:00 AM ISTIn a study of patients with borderline resectable pancreatic cancer, combination chemotherapy with modified FOLFIRINOX before surgery increased...
Sanofi Global Health unveils new brand Impact for distribution of 30 medicines in low-income countries Ruchika Sharma4 July 2022 5:44 PM ISTConsidered essential by the World Health Organization, the medicines cover a wide range of therapeutic areas, including diabetes, cardiovascular...
